"The agreement provides for various payment terms including the payment of ongoing
royalties based on the volume of units sold, commencing at certain agreed volume
threshold and the net sale price of the customer’s products. The royalties remain in effect
throughout the life of the licensed product."
............I'll go with that!
- Forums
- ASX - By Stock
- BRN
- Ann: First Akida IP License Agreement
Ann: First Akida IP License Agreement, page-58
-
-
- There are more pages in this discussion • 725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.010(5.88%) |
Mkt cap ! $347.7M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.0¢ | $413.5K | 2.350M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 1283114 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1985197 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 1053001 | 0.175 |
33 | 1911991 | 0.170 |
63 | 1770227 | 0.165 |
70 | 1565179 | 0.160 |
26 | 1127731 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1986431 | 54 |
0.185 | 1139288 | 28 |
0.190 | 1776209 | 29 |
0.195 | 910971 | 14 |
0.200 | 1058417 | 38 |
Last trade - 11.50am 14/08/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online